Herbert Lepor, MD, and Danil V. Makarov, MD, MHS, discuss the case of a 58 year-old African American male with lower urinary tract symptoms in Part 1 of this episode of Curbside Consult. They delve into whether a PSA test should be conducted, focusing on key risk factors for this particular patient. The faculty also cover results from the PLCO study and the ESRPC study with key takeaways about weighing the risks and benefits of preventive testing in prostate cancer.
Learn more about Herbert Lepor, MD.
Learn more about Danil V.Makarov, MD, MHS.
Related Reading
Schröder FH, Hugosson J, Roobol MJ, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328.
Andriole GL, Crawford ED, Grubb RL 3rd., et al. (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med360:1310–1319.
